A neoplasm arising from the epithelial cells of the thymus. Although thymomas are usually encapsulated tumors, they may invade the capsule and infiltrate the surrounding tissues or even metastasize to distant anatomic sites. The following morphologic subtypes are currently recognized: type A, type B, type AB, metaplastic, micronodular, microscopic, and sclerosing thymoma. Thymomas type B are further subdivided into types B1, B2, and B3. Thymoma type B3 usually has the most aggressive clinical course. [ NCIT:C3411 ]
Synonyms: primary thymic epithelial tumor primary thymic epithelial tumour thymoma (disease) thymoma primary thymic epithelial neoplasm
Term information
- GARD:16922 (MONDO:GARD)
- MedDRA:10043670 (Orphanet:99867/e)
- NCIT:C3411 (MONDO:equivalentTo)
- DOID:3275 (MONDO:equivalentTo)
- icd11.foundation:33869057 (https://orcid.org/0000-0002-3458-4839)
- ICD10CM:D15.0 (Orphanet:99867/ntbt)
- ICDO:8580/1 (NCIT:C3411)
- MESH:D013945 (https://orcid.org/0000-0003-1967-3726)
- Orphanet:99867 (MONDO:equivalentTo)
- MEDGEN:52743 (MONDO:equivalentTo)
- SCTID:444231005 (MONDO:equivalentTo)
- EFO:1000581 (MONDO:equivalentTo)
- ICD9:239.89 (MONDO:relatedTo)
- ONCOTREE:THYM (MONDO:equivalentTo)
- HP:0100522 (MONDO:otherHierarchy)
- UMLS:C0040100 (MONDO:equivalentTo)
matrix_llm__txgnn_cancer, gard_rare, ordo_disorder, matrix_txgnn_grouping_cancer_or_benign_tumor, matrix_llm__medical_specialization_oncology, matrix_llm__txgnn_, harrisons_view_endocrine_system_disorder, mondo_top_grouping_member, matrix_llm__medical_specialization_member, matrix_llm__is_glucose_dysfunction_false, harrisons_view_immune_system_disorder, matrix_txgnn_grouping_endocrine_system_disorder, nord_rare, matrix_included, matrix_llm__is_glucose_dysfunction_member, mondo_top_grouping_cancer_or_benign_tumor, matrix_llm__is_pathogen_caused_false, matrix_txgnn_grouping_member, rare, mondo_top_grouping_immune_system_disorder, orphanet_rare, matrix_llm__tag_qaly_lost_member, matrix_llm__anatomical_immune_disorder, otar, matrix_llm__medical_specialization_hematology, mondo_top_grouping_hematologic_disorder, matrix_llm__tag_qualy_lost_other, mondo_top_grouping_endocrine_system_disorder, matrix_llm__tag_existing_treatment_member, matrix_llm__txgnn_autoimmune_diseases, matrix_llm__is_pathogen_caused_member, matrix_llm__txgnn_thyroid_related_disease, matrix_llm__tag_qaly_lost_medium, harrisons_view_hematologic_disorder, matrix_llm__tag_existing_treatment_true, matrix_llm__txgnn_member, harrisons_view_cancer_or_benign_tumor, harrisons_view_member, matrix_llm__is_cancer_member, matrix_llm__is_cancer_true, matrix_llm__anatomical_member, matrix_llm__anatomical_lymphatic_disorder
http://purl.obolibrary.org/obo/mondo/sources/icd11foundation/33869057
http://identifiers.org/snomedct/444231005
http://identifiers.org/medgen/52743
http://purl.obolibrary.org/obo/NCIT_C3411
http://www.ebi.ac.uk/efo/EFO_1000581
http://www.orpha.net/ORDO/Orphanet_99867
http://purl.obolibrary.org/obo/DOID_3275
http://linkedlifedata.com/resource/umls/id/C0040100
http://identifiers.org/mesh/D013945